CT angiography (CTA) technology, as a non-invasive or minimally invasive examination method, is commonly used in the clinic to obtain vascular network images, and iodinated contrast agents play a vital role in it. At present, the second-generation non-ionic contrast agent ioversol are most commonly used in CTA, but its preparation process is complicated, the manufacture technology of it is high, and it is associated with some adverse drug reactions (ADRs), such as allergies and drug toxicity. In this work, based on the low melting point (29.78℃) and low viscosity of liquid metal gallium, it was used for the first time as an angiographic contrast agent for in vivo hepatic artery angiography. According to the statistical analysis of the smallest visible diameter of the hepatic artery and the contrast effect between the blood vessels and their surrounding tissues in CT images, we confirmed that compared with CT imaging using ioversol for hepatic artery angiography, that using liquid metal gallium produced more intuitive and excellent vascular imaging effects.In other words, the use of liquid metal gallium as an angiographic contrast agent has a certain value in living organ angiography. However, the lower overall image quality and higher side-effects of liquid metal gallium in CTA indicate that the use of liquid metal gallium as a contrast agent for living organs still needs to overcome some problems, such as the metallic artefacts and its hypertonicity. Only in this way can liquid metal gallium become a potential contrast agent candidate for angiography in animal experiments and possibly even in the clinical.